Skip to main content
Top
Published in: Journal of General Internal Medicine 5/2016

01-05-2016 | Original Research

Primary Care Patients with Drug Use Report Chronic Pain and Self-Medicate with Alcohol and Other Drugs

Authors: Daniel P. Alford, MD, MPH, Jacqueline S. German, MPH, Jeffrey H. Samet, MD, MA, MPH, Debbie M. Cheng, ScD, Christine A. Lloyd-Travaglini, MPH, Richard Saitz, MD, MPH

Published in: Journal of General Internal Medicine | Issue 5/2016

Login to get access

ABSTRACT

BACKGROUND

Chronic pain is common among patients with drug use disorders. The prevalence of chronic pain and its consequences in primary care patients who use drugs is unknown.

OBJECTIVES

To examine: 1) the prevalence of chronic pain and pain-related dysfunction among primary care patients who screen positive for drug use, and 2) the prevalence of substance use to self-medicate chronic pain in this population.

DESIGN

This was a cross-sectional analysis.

PARTICIPANTS

This study included 589 adult patients who screened positive for any illicit drug use or prescription drug misuse, recruited from an urban, hospital-based primary care practice.

MAIN MEASURES

Both pain and pain-related dysfunction were assessed by numeric rating scales, and grouped as: (0) none, (1–3) mild, (4–6) moderate, (7–10) severe. Questions were asked about the use of substances to treat pain.

KEY RESULTS

Among 589 participants, chronic pain was reported by 87 % (95 % CI: 84–90 %), with 13 % mild, 24 % moderate and 50 % severe. Pain-related dysfunction was reported by 74 % (95 % CI: 70–78 %), with 15 % mild, 23 % moderate, and 36 % severe. Of the 576 that used illicit drugs (i.e., marijuana, cocaine, and/or heroin), 51 % reported using to treat pain (95 % CI: 47–55 % ). Of the 121 with prescription drug misuse, 81 % (95 % CI: 74–88 %) used to treat pain. Of the 265 participants who reported any heavy drinking in the past 3 months, 38 % (95 % CI: 32–44 %) did so to treat pain compared to 79 % (95 % CI: 68–90 %) of the 57 high-risk alcohol users.

CONCLUSIONS

Chronic pain and pain-related dysfunction were the norm for primary care patients who screened positive for drug use, with nearly one-third reporting both severe pain and severe pain-related dysfunction. Many patients using illicit drugs, misusing prescription drugs and using alcohol reported doing so in order to self-medicate their pain. Pain needs to be addressed when patients are counseled about their substance use.
Literature
1.
go back to reference Institute of Medicine Committee on Advancing Pain Research Care and Education. The National Academies Collection: Reports funded by National Institutes of Health. Relieving Pain in America: A Blueprint for Transforming Prevention, Care, Education, and Research. Washington (DC): National Academies Press (US) National Academy of Sciences; 2011. Institute of Medicine Committee on Advancing Pain Research Care and Education. The National Academies Collection: Reports funded by National Institutes of Health. Relieving Pain in America: A Blueprint for Transforming Prevention, Care, Education, and Research. Washington (DC): National Academies Press (US) National Academy of Sciences; 2011.
2.
go back to reference Trafton JA, Oliva EM, Horst DA, Minkel JD, Humphreys K. Treatment needs associated with pain in substance use disorder patients: implications for concurrent treatment. Drug Alcohol Depend. 2004;73:23–31.CrossRefPubMed Trafton JA, Oliva EM, Horst DA, Minkel JD, Humphreys K. Treatment needs associated with pain in substance use disorder patients: implications for concurrent treatment. Drug Alcohol Depend. 2004;73:23–31.CrossRefPubMed
3.
go back to reference Rosenblum A, Joseph H, Fong C, Kipnis S, Cleland C, Portenoy RK. Prevalence and characteristics of chronic pain among chemically dependent patients in methadone maintenance and residential treatment facilities. JAMA. 2003;289:2370–2378.CrossRefPubMed Rosenblum A, Joseph H, Fong C, Kipnis S, Cleland C, Portenoy RK. Prevalence and characteristics of chronic pain among chemically dependent patients in methadone maintenance and residential treatment facilities. JAMA. 2003;289:2370–2378.CrossRefPubMed
4.
go back to reference Jamison RN, Kauffman J, Katz NP. Characteristics of methadone maintenance patients with chronic pain. J Pain Symptom Manag. 2000;19:53–62.CrossRef Jamison RN, Kauffman J, Katz NP. Characteristics of methadone maintenance patients with chronic pain. J Pain Symptom Manag. 2000;19:53–62.CrossRef
5.
go back to reference Barry DT, Savant JD, Beitel M, Cutter CJ, Moore BA, Schottenfeld RS, Fiellin DA. Pain and associated substance use among opioid dependent individuals seeking office‐based treatment with buprenorphine–naloxone: a needs assessment study. Am J Addict. 2013;22(3):212–217.CrossRefPubMedPubMedCentral Barry DT, Savant JD, Beitel M, Cutter CJ, Moore BA, Schottenfeld RS, Fiellin DA. Pain and associated substance use among opioid dependent individuals seeking office‐based treatment with buprenorphine–naloxone: a needs assessment study. Am J Addict. 2013;22(3):212–217.CrossRefPubMedPubMedCentral
7.
go back to reference Saitz R, Palfai TA, Cheng DM, Alford DP, Bernstein JA, Lloyd-Travglini CA, Meli SM, Chaisson CE, Samet JH. Screening and brief intervention for drug use in primary care: the ASPIRE randomized clinical trial. JAMA. 2014;312(5):502–513.CrossRefPubMedPubMedCentral Saitz R, Palfai TA, Cheng DM, Alford DP, Bernstein JA, Lloyd-Travglini CA, Meli SM, Chaisson CE, Samet JH. Screening and brief intervention for drug use in primary care: the ASPIRE randomized clinical trial. JAMA. 2014;312(5):502–513.CrossRefPubMedPubMedCentral
8.
go back to reference McNeely J, Strauss SM, Saitz R, Cleland CM, Palamar JJ, Rotrosen J, Gourevitch MN. A brief patient self-administered substance use screening tool for primary care: two-site validation study of the Substance Use Brief Screen (SUBS). Amer J Med. 2015. doi:10.1016/j.amjmed.2015.02.007.PubMed McNeely J, Strauss SM, Saitz R, Cleland CM, Palamar JJ, Rotrosen J, Gourevitch MN. A brief patient self-administered substance use screening tool for primary care: two-site validation study of the Substance Use Brief Screen (SUBS). Amer J Med. 2015. doi:10.​1016/​j.​amjmed.​2015.​02.​007.PubMed
9.
go back to reference Manwell LB, Fleming MF, Johnson K, Barry KL. Tobacco, alcohol, and drug use in a primary care sample: 90-day prevalence and associated factors. J Addict Dis. 1998;17(1):67–81.CrossRefPubMed Manwell LB, Fleming MF, Johnson K, Barry KL. Tobacco, alcohol, and drug use in a primary care sample: 90-day prevalence and associated factors. J Addict Dis. 1998;17(1):67–81.CrossRefPubMed
10.
11.
12.
go back to reference Chilcoat HD, Breslau N. Posttraumatic stress disorder and drug disorders: testing causal pathways. Arch Gen Psychiatry. 1998;55(10):913–917.CrossRefPubMed Chilcoat HD, Breslau N. Posttraumatic stress disorder and drug disorders: testing causal pathways. Arch Gen Psychiatry. 1998;55(10):913–917.CrossRefPubMed
13.
go back to reference Mariani JJ, Khantzian EJ, Levin FR. The self-medication hypothesis and psychostimulant treatment of cocaine dependence: an update. Am J Addict. 2014;23(2):189–193.CrossRefPubMedPubMedCentral Mariani JJ, Khantzian EJ, Levin FR. The self-medication hypothesis and psychostimulant treatment of cocaine dependence: an update. Am J Addict. 2014;23(2):189–193.CrossRefPubMedPubMedCentral
14.
go back to reference Weiss RD, Potter JS, Griffin ML, McHugh RK, Haller D, Jacobs P, Gardin J, Fischer D, Rosen KD. Reasons for opioid use among patients with dependence on prescription opioids: the role of chronic pain. J Subst Abus Treat. 2014;47(2):140–145.CrossRef Weiss RD, Potter JS, Griffin ML, McHugh RK, Haller D, Jacobs P, Gardin J, Fischer D, Rosen KD. Reasons for opioid use among patients with dependence on prescription opioids: the role of chronic pain. J Subst Abus Treat. 2014;47(2):140–145.CrossRef
15.
go back to reference Roy-Byrne P, Bumgardner K, Krupski A, Dunn C, Ries R, Donovan D, et al. Brief intervention for problem drug use in safety-net primary care settings: a randomized clinical trial. JAMA. 2014;312(5):492–501.CrossRefPubMedPubMedCentral Roy-Byrne P, Bumgardner K, Krupski A, Dunn C, Ries R, Donovan D, et al. Brief intervention for problem drug use in safety-net primary care settings: a randomized clinical trial. JAMA. 2014;312(5):492–501.CrossRefPubMedPubMedCentral
16.
go back to reference Humeniuk R, Ali R, Babor TF, et al. Validation of the alcohol, smoking and substance involvement screening test (ASSIST). Addiction. 2008;103(6):1039–1047.CrossRefPubMed Humeniuk R, Ali R, Babor TF, et al. Validation of the alcohol, smoking and substance involvement screening test (ASSIST). Addiction. 2008;103(6):1039–1047.CrossRefPubMed
17.
go back to reference Von Korff M, Ormel J, Keefe FJ, Dworkin SF. Grading the severity of chronic pain. Pain. 1992;50(2):133–149.CrossRef Von Korff M, Ormel J, Keefe FJ, Dworkin SF. Grading the severity of chronic pain. Pain. 1992;50(2):133–149.CrossRef
18.
go back to reference Von Korff M. Assessment of chronic pain in epidemiological and health services research: empirical bases and new directions. In: Turk DC, Melzack R, eds. Handbook of pain assessment. 3rd ed. New York: Guilford Press; 2011:455–473. Von Korff M. Assessment of chronic pain in epidemiological and health services research: empirical bases and new directions. In: Turk DC, Melzack R, eds. Handbook of pain assessment. 3rd ed. New York: Guilford Press; 2011:455–473.
19.
go back to reference Bush K, Kivlahan DR, McDonell MB, Fihn SD, Bradley KA. The AUDIT alcohol consumption questions (AUDIT-C): an effective brief screening test for problem drinking. Arch Intern Med. 1998;158(16):1789–1795.CrossRefPubMed Bush K, Kivlahan DR, McDonell MB, Fihn SD, Bradley KA. The AUDIT alcohol consumption questions (AUDIT-C): an effective brief screening test for problem drinking. Arch Intern Med. 1998;158(16):1789–1795.CrossRefPubMed
20.
go back to reference EuroQol Group. EuroQol—a new facility for the measurement of health-related quality of life. Health Policy. 1990;16(3):199–208.CrossRef EuroQol Group. EuroQol—a new facility for the measurement of health-related quality of life. Health Policy. 1990;16(3):199–208.CrossRef
22.
go back to reference Norman SB, Cissel SH, Means-Christensen AJ, Stein M. Development and validation of an overall anxiety severity and impairment scale (OASIS). Depress Anxiety. 2006;23(4):245–249.CrossRefPubMed Norman SB, Cissel SH, Means-Christensen AJ, Stein M. Development and validation of an overall anxiety severity and impairment scale (OASIS). Depress Anxiety. 2006;23(4):245–249.CrossRefPubMed
23.
go back to reference Breivik H, Borchgrevink PC, Allen SM, et al. Assessment of pain. Br J Anaesth. 2008;101(1):17–24.CrossRefPubMed Breivik H, Borchgrevink PC, Allen SM, et al. Assessment of pain. Br J Anaesth. 2008;101(1):17–24.CrossRefPubMed
24.
go back to reference Dzau VJ, Pizzo PA. Relieving pain in america: insights from an institute of medicine committee. JAMA. 2014;312(15):1507–1508.CrossRefPubMed Dzau VJ, Pizzo PA. Relieving pain in america: insights from an institute of medicine committee. JAMA. 2014;312(15):1507–1508.CrossRefPubMed
25.
go back to reference Gureje O, Von Korff M, Simon GE, Gater R. Persistent pain and well-being: a world health organization study in primary care. JAMA. 1998;280(2):147–151.CrossRefPubMed Gureje O, Von Korff M, Simon GE, Gater R. Persistent pain and well-being: a world health organization study in primary care. JAMA. 1998;280(2):147–151.CrossRefPubMed
26.
go back to reference Savage SR, Schofferman J. Pharmacological therapies of pain in drug and alcohol addictions. In: Miller N, Gold M, eds. Pharmacological therapies for drug and alcohol addictions. New York: Dekker; 1995:373–409. Savage SR, Schofferman J. Pharmacological therapies of pain in drug and alcohol addictions. In: Miller N, Gold M, eds. Pharmacological therapies for drug and alcohol addictions. New York: Dekker; 1995:373–409.
27.
go back to reference Kennedy J, Roll JM, Schraudner T, Murphy S, McPherson S. Prevalence of persistent pain in the US adult population: new data from the 2010 national health interview survey. J Pain. 2014;15(10):979–984.CrossRefPubMed Kennedy J, Roll JM, Schraudner T, Murphy S, McPherson S. Prevalence of persistent pain in the US adult population: new data from the 2010 national health interview survey. J Pain. 2014;15(10):979–984.CrossRefPubMed
28.
go back to reference Cheatle MD, Gallagher RM. Chronic pain and comorbid mood and substance use disorders: a biopsychosocial treatment approach. Curr Psychiatry Rep. 2006;8(5):371–376.CrossRefPubMed Cheatle MD, Gallagher RM. Chronic pain and comorbid mood and substance use disorders: a biopsychosocial treatment approach. Curr Psychiatry Rep. 2006;8(5):371–376.CrossRefPubMed
29.
go back to reference Gore M, Sadosky A, Stacey BR, Tai KS, Leslie D. The burden of chronic low back pain: clinical comorbidities, treatment patterns, and health care costs in usual care settings. Spine. 2012;37(11):E668–E677.CrossRefPubMed Gore M, Sadosky A, Stacey BR, Tai KS, Leslie D. The burden of chronic low back pain: clinical comorbidities, treatment patterns, and health care costs in usual care settings. Spine. 2012;37(11):E668–E677.CrossRefPubMed
30.
go back to reference Elliott AM, Smith BH, Hannaford PC, Smith WC, Chambers WA. The course of chronic pain in the community: results of a 4-year follow-up study. Pain. 2002;99(1):299–307.CrossRefPubMed Elliott AM, Smith BH, Hannaford PC, Smith WC, Chambers WA. The course of chronic pain in the community: results of a 4-year follow-up study. Pain. 2002;99(1):299–307.CrossRefPubMed
32.
go back to reference Bui Q, Doescher M, Takeuchi D, Taylor V. Immigration, acculturation and chronic back and neck problems among Latino-Americans. J Immigr Minor Health. 2011;13(2):194–201.CrossRefPubMedPubMedCentral Bui Q, Doescher M, Takeuchi D, Taylor V. Immigration, acculturation and chronic back and neck problems among Latino-Americans. J Immigr Minor Health. 2011;13(2):194–201.CrossRefPubMedPubMedCentral
33.
go back to reference Boys A, Marsden J, Strang J. Understanding reasons for drug use amongst young people: a functional perspective. Health Educ Res. 2001;16(4):457–469.CrossRefPubMed Boys A, Marsden J, Strang J. Understanding reasons for drug use amongst young people: a functional perspective. Health Educ Res. 2001;16(4):457–469.CrossRefPubMed
34.
go back to reference Gonzalez JMR, Walters ST, Lerch J, Taxman FS. The relationship between drug use, drug-related arrests, and chronic pain among adults on probation. J Subst Abus Treat. 2015;53:33–38.CrossRef Gonzalez JMR, Walters ST, Lerch J, Taxman FS. The relationship between drug use, drug-related arrests, and chronic pain among adults on probation. J Subst Abus Treat. 2015;53:33–38.CrossRef
35.
go back to reference Potter JS, Chakrabarti A, Domier CP, Hillhouse MP, Weiss RD, Ling W. Pain and continued opioid use in individuals receiving buprenorphine–naloxone for opioid detoxification: secondary analyses from the clinical trials network. J Subst Abus Treat. 2010;38:S80–S86.CrossRef Potter JS, Chakrabarti A, Domier CP, Hillhouse MP, Weiss RD, Ling W. Pain and continued opioid use in individuals receiving buprenorphine–naloxone for opioid detoxification: secondary analyses from the clinical trials network. J Subst Abus Treat. 2010;38:S80–S86.CrossRef
36.
go back to reference Larson MJ, Paasche-Orlow M, Cheng DM, Lloyd-Travaglini C, Saitz R, Samet JH. Persistent pain is associated with substance use after detoxification: a prospective cohort analysis. Addiction. 2007;102(5):752–760.CrossRefPubMed Larson MJ, Paasche-Orlow M, Cheng DM, Lloyd-Travaglini C, Saitz R, Samet JH. Persistent pain is associated with substance use after detoxification: a prospective cohort analysis. Addiction. 2007;102(5):752–760.CrossRefPubMed
37.
go back to reference Fox AD, Sohler NL, Starrels JL, Ning Y, Giovanniello A, Cunningham CO. Pain is not associated with worse office-based buprenorphine treatment outcomes. Subst Abus. 2012;33(4):361–365.CrossRefPubMedPubMedCentral Fox AD, Sohler NL, Starrels JL, Ning Y, Giovanniello A, Cunningham CO. Pain is not associated with worse office-based buprenorphine treatment outcomes. Subst Abus. 2012;33(4):361–365.CrossRefPubMedPubMedCentral
38.
go back to reference Hingson R, Compton WM. Screening and brief intervention and referral to treatment for drug use in primary care: back to the drawing board. JAMA. 2014;312(5):488–489.CrossRefPubMed Hingson R, Compton WM. Screening and brief intervention and referral to treatment for drug use in primary care: back to the drawing board. JAMA. 2014;312(5):488–489.CrossRefPubMed
39.
go back to reference Samet JH, Rollnick S, Barnes H, Beyond CAGE. A brief clinical approach after detection of substance abuse. Arch Intern Med. 1996;156(20):2287–2293.CrossRefPubMed Samet JH, Rollnick S, Barnes H, Beyond CAGE. A brief clinical approach after detection of substance abuse. Arch Intern Med. 1996;156(20):2287–2293.CrossRefPubMed
40.
go back to reference Barry DT, Cutter CJ, Beitel M, Liong C, Schottenfeld RS. Cognitive-behavioral therapy and educational counseling for chronic pain and opioid dependence. Drug Alcohol Depend. 2015;146:e218–e219. Barry DT, Cutter CJ, Beitel M, Liong C, Schottenfeld RS. Cognitive-behavioral therapy and educational counseling for chronic pain and opioid dependence. Drug Alcohol Depend. 2015;146:e218–e219.
41.
go back to reference Madras BK, Compton WM, Avula D, Stegbauer T, Stein JB, Clark HW. Screening, brief interventions, referral to treatment (SBIRT) for illicit drug and alcohol use at multiple healthcare sites: comparison at intake and 6 months later. Drug Alcohol Depend. 2009;99(1):280–295.CrossRefPubMedPubMedCentral Madras BK, Compton WM, Avula D, Stegbauer T, Stein JB, Clark HW. Screening, brief interventions, referral to treatment (SBIRT) for illicit drug and alcohol use at multiple healthcare sites: comparison at intake and 6 months later. Drug Alcohol Depend. 2009;99(1):280–295.CrossRefPubMedPubMedCentral
Metadata
Title
Primary Care Patients with Drug Use Report Chronic Pain and Self-Medicate with Alcohol and Other Drugs
Authors
Daniel P. Alford, MD, MPH
Jacqueline S. German, MPH
Jeffrey H. Samet, MD, MA, MPH
Debbie M. Cheng, ScD
Christine A. Lloyd-Travaglini, MPH
Richard Saitz, MD, MPH
Publication date
01-05-2016
Publisher
Springer US
Published in
Journal of General Internal Medicine / Issue 5/2016
Print ISSN: 0884-8734
Electronic ISSN: 1525-1497
DOI
https://doi.org/10.1007/s11606-016-3586-5

Other articles of this Issue 5/2016

Journal of General Internal Medicine 5/2016 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.